As part of a continuing study of the synthesis and chemistry of new, substituted pentacyclo(5.4.0.0²，⁶.0³，¹º.0⁵，⁹)undecanes, the following compounds have been synthesized: 1: X=O, Y=SiMe_3; 2: X=CH_2, Y=SiMe_3; 3: X=O, Y=Cl; 6: X=OAc, Y=H; 8: X=OC(O)Ph, Y=H; 9: X=OSO_2Ph, Y=H; 11: X=OH, Y=H; 12: X=OMe, Y=H; 14: X=CHSiMe_3, Y=SiMe_3; 15: X=OH, Y=Cl; 16: X=OAc, Y=Cl; 17: X=OMe, Y=Cl. An important objective of this work is to prepare new polycyclic cage compounds which can be utilized as intermediates for the synthesis of new, substituted tricyclopentanoid natural products (triquinanes) and related systems. Compounds 1-4 were identified as target molecules in this connection.

Neurodegenerative disorders, including Alzheimer's and Parkinson's disease, and the development of neuroprotective agents have received significant research attention in recent years. Development of novel imaging techniques to study the biological mechanisms involved in the progression of these disorders have become an area of research interest. The design of novel small molecule imaging probes in combination with modem imaging techniques may provide information on neuroprotective binding site• interactions and would assist in the design of novel biological assay methods. Techniques to visualize physiological or pathophysiological changes in proteins and living cells have become increasingly important in biomedical sciences, especially fluorescent techniques. Fluorescent ligands in combination with sophisticated fluorescent imaging technologies are useful tools to analyze and clarify the roles of biomolecules in living cells, affording high spatial and temporal resolution. This study is based on the development of polycyclic fluorescent ligands, which may be used in the study of receptor-ligand and/or enzyme-ligand interactions, utilizing these fluorescently labeled ligands in combination with fluorescent imaging techniques. Fluorescent conjugates with high affinity for the• N-methyl-D-aspartate (NMDA) receptor, voltage gated calcium channels (VGCC) and/or the nitric oxide synthase (NOS) enzyme were designed and synthesised with the aim to directly measure binding of these novel molecules to receptors and/or enzymes. The first goal was to develop fluorescent ligands that exhibit similar inhibitory activity on NOS compared to the well-known selective neuronal NOS inhibitor 7-nitroindazole (7-NI). Polycyclic compounds, including amantadine and pentacycloundecane derivatives, were conjugated to fluorescent moieties that resemble the structure of 7-NI. It was thought that the lipophilic nature of the polycyclic compounds would increase the activity of the fluorescent moieties by facilitating increased blood brain barrier permeability and penetration through cell membranes. This would also potentially increase the selectivity of the novel conjugated compounds as selective neuronal NOS inhibitors, similar to 7-NI. The results from the NOS inhibition studies indicated that the novel fluorescent conjugates (5-14) inhibited the NOS enzyme at micromolar concentrations. Although none of the novel fluorescent polycyclic compounds were found to be more potent than 7-NI (IC50 = 0.11 11M), the indazole pentacyclorindecane (5), the coumarin-adamantane (7), the dansyl-adamantane (8), and the cyanoisoindole-adamantane (11) conjugates, exhibited IC5o values below 1 uM. These compounds could possibly be used as molecular probes in the development of high-throughput screening or competitive NOS displacement assays. Further studies on isoform selectivity will elaborate on the potential of these compounds as fluorescent molecular probes. The aforementioned fluorescent derivatives were further developed resulting in a series of novel fluorescent polycyclic conjugates with potent NOS inhibition indicating the potential of these compounds as neuroprotective agents. Due to the polycyclic structure's inherent inhibitory activity towards the NMDA receptor and VGCC we evaluated these derivatives as possible multifunctional neuroprotective agents acting on various neuroprotective targets. In the biological studies it was observed that four adamantane fluorescent compounds (7, 8, 10, 11) exhibited a high degree of inhibitory activity against the NOS enzyme and NMDA receptor and blocked VGCC. The fluorescent compounds were further able to scavange detrimental neurodegenerative free radicals. In silica studies also predicted a high degree of oral bioavailability and that these novel compounds should be effectively transported across the blood brain barrier. Taking the positive findings on the inhibition of the NMDA receptor and VGCC activity of the novel fluorescent polycyclic ligands into account we focused on the expansion of this series. This resulted in the synthesis of a series of fluorescent derivatives utilizing adamantane-3-aminopropanol as an intermediate to extend the chain length between the adamantyl and fluorescent moieties, to potentially reduce sterical hindrance and increase activity. These novel adamantane-3-aminopropanol fluorescent ligands were also evaluated for inhibition of the NMDA receptor and VGCC. The coumarin-, dansyl- and cyanoisoindole adamantane-3-aminopropanol fluorescent conjugates (15, 16, 19) displayed significant VGCC inhibition, with the dansyl (16) and di-nitrobenzene (20) fluorescent derivatives exhibiting NMDA receptor antagonistic activity. All these compounds showed improved activity when compared to known NMDA receptor and VGCC inhibitors in this class. Generally it was observed that the increased chain length analogues had improved VGCC inhibition and NMDA receptor activity when compared to their directly• conjugated counterparts. This led to the conclusion that an increase in chain length might indicate deeper immersion into the NMDA receptor and VGCC which may be necessary for stronger interaction with their putative binding sites. The dansyl analogue, N-[3-(1-adamantylamino)propyl]-5- dimethylaminonaphthalene-1-sulfonamide (16), was further used as a fluorescent NMDA receptor ligand in a fluorescent competition assay, utilizing known NMDA receptor inhibitors to demonstrate the possible applications of these novel fluorescent analogues and their benefit over the use of hazardous and expensive radioligand binding studies. Further investigation on the application of these derivatives, especially on the NOS enzyme and the NMDA receptor, will develop their potential as fluorescent ligands in the study of neurodegeneration and may also yield novel therapeutic agents against neurodegenerative disorders. / PhD (Pharmaceutical Chemistry), North-West University, Potchefstroom Campus, 2012

Neurodegenerative disorders, including Alzheimer's and Parkinson's disease, and the development of neuroprotective agents have received significant research attention in recent years. Development of novel imaging techniques to study the biological mechanisms involved in the progression of these disorders have become an area of research interest. The design of novel small molecule imaging probes in combination with modem imaging techniques may provide information on neuroprotective binding site• interactions and would assist in the design of novel biological assay methods. Techniques to visualize physiological or pathophysiological changes in proteins and living cells have become increasingly important in biomedical sciences, especially fluorescent techniques. Fluorescent ligands in combination with sophisticated fluorescent imaging technologies are useful tools to analyze and clarify the roles of biomolecules in living cells, affording high spatial and temporal resolution. This study is based on the development of polycyclic fluorescent ligands, which may be used in the study of receptor-ligand and/or enzyme-ligand interactions, utilizing these fluorescently labeled ligands in combination with fluorescent imaging techniques. Fluorescent conjugates with high affinity for the• N-methyl-D-aspartate (NMDA) receptor, voltage gated calcium channels (VGCC) and/or the nitric oxide synthase (NOS) enzyme were designed and synthesised with the aim to directly measure binding of these novel molecules to receptors and/or enzymes. The first goal was to develop fluorescent ligands that exhibit similar inhibitory activity on NOS compared to the well-known selective neuronal NOS inhibitor 7-nitroindazole (7-NI). Polycyclic compounds, including amantadine and pentacycloundecane derivatives, were conjugated to fluorescent moieties that resemble the structure of 7-NI. It was thought that the lipophilic nature of the polycyclic compounds would increase the activity of the fluorescent moieties by facilitating increased blood brain barrier permeability and penetration through cell membranes. This would also potentially increase the selectivity of the novel conjugated compounds as selective neuronal NOS inhibitors, similar to 7-NI. The results from the NOS inhibition studies indicated that the novel fluorescent conjugates (5-14) inhibited the NOS enzyme at micromolar concentrations. Although none of the novel fluorescent polycyclic compounds were found to be more potent than 7-NI (IC50 = 0.11 11M), the indazole pentacyclorindecane (5), the coumarin-adamantane (7), the dansyl-adamantane (8), and the cyanoisoindole-adamantane (11) conjugates, exhibited IC5o values below 1 uM. These compounds could possibly be used as molecular probes in the development of high-throughput screening or competitive NOS displacement assays. Further studies on isoform selectivity will elaborate on the potential of these compounds as fluorescent molecular probes. The aforementioned fluorescent derivatives were further developed resulting in a series of novel fluorescent polycyclic conjugates with potent NOS inhibition indicating the potential of these compounds as neuroprotective agents. Due to the polycyclic structure's inherent inhibitory activity towards the NMDA receptor and VGCC we evaluated these derivatives as possible multifunctional neuroprotective agents acting on various neuroprotective targets. In the biological studies it was observed that four adamantane fluorescent compounds (7, 8, 10, 11) exhibited a high degree of inhibitory activity against the NOS enzyme and NMDA receptor and blocked VGCC. The fluorescent compounds were further able to scavange detrimental neurodegenerative free radicals. In silica studies also predicted a high degree of oral bioavailability and that these novel compounds should be effectively transported across the blood brain barrier. Taking the positive findings on the inhibition of the NMDA receptor and VGCC activity of the novel fluorescent polycyclic ligands into account we focused on the expansion of this series. This resulted in the synthesis of a series of fluorescent derivatives utilizing adamantane-3-aminopropanol as an intermediate to extend the chain length between the adamantyl and fluorescent moieties, to potentially reduce sterical hindrance and increase activity. These novel adamantane-3-aminopropanol fluorescent ligands were also evaluated for inhibition of the NMDA receptor and VGCC. The coumarin-, dansyl- and cyanoisoindole adamantane-3-aminopropanol fluorescent conjugates (15, 16, 19) displayed significant VGCC inhibition, with the dansyl (16) and di-nitrobenzene (20) fluorescent derivatives exhibiting NMDA receptor antagonistic activity. All these compounds showed improved activity when compared to known NMDA receptor and VGCC inhibitors in this class. Generally it was observed that the increased chain length analogues had improved VGCC inhibition and NMDA receptor activity when compared to their directly• conjugated counterparts. This led to the conclusion that an increase in chain length might indicate deeper immersion into the NMDA receptor and VGCC which may be necessary for stronger interaction with their putative binding sites. The dansyl analogue, N-[3-(1-adamantylamino)propyl]-5- dimethylaminonaphthalene-1-sulfonamide (16), was further used as a fluorescent NMDA receptor ligand in a fluorescent competition assay, utilizing known NMDA receptor inhibitors to demonstrate the possible applications of these novel fluorescent analogues and their benefit over the use of hazardous and expensive radioligand binding studies. Further investigation on the application of these derivatives, especially on the NOS enzyme and the NMDA receptor, will develop their potential as fluorescent ligands in the study of neurodegeneration and may also yield novel therapeutic agents against neurodegenerative disorders. / PhD (Pharmaceutical Chemistry), North-West University, Potchefstroom Campus, 2012

In this study a number of cage alkenes were synthesised and tested for activity towards ringopening metathesis polymerisation (ROMP) with the commercially available catalysts 55 (Grubbs-I) and 56 (Grubbs-II). The first group of monomers are derivatives of tetracyclo[6.3.0.04,1105,9]undec-2-en-6-one (1). The synthesis of these cage alkenes are summarised in Scheme 7.1. The cage alkene 126b was synthesised by a Diels-Alder reaction between 1 and hexachlorocyclopentadiene (9, Scheme 7.2). The geometry of 126b was determined from XRD data. Knowledge of the geometry of 126b also established the geometry of 127 since conformational changes during the conversion from 126b to 127 are unlikely. Synthesis of the cage alkene 125 by the cycloaddition of 9 to 118 failed. The cage alkene exo-11- hydroxy-4,5,6,7,16,16-hexachlorohexacyclo[7.6.1.03,8.02,13.010,14]hexa-dec-5-ene (124, Scheme 7.3) could therefore not be prepared. Synthesis of 125 by reduction of 126b with various reduction systems was not successful. Theoretical aspects of these reactions were investigated with molecular modelling. A possible explanation for the unreactive nature of 126b towards reduction is presented, but the lack of reactivity of 118 towards 9 eluded clear explanations. The synthesis of cage alkenes from 4-isopropylidenepentacyclo[5.4.0.02,6.03,10.05,9]-undecane-8,11- dione (23) did not meet with much success (Scheme 7.4). Numerous synthetic methods were investigated to affect the transformation from 134a/134b to 135 (Scheme 7.5). These attempts evolved into theoretical investigations to uncover the reasons for the observed reactivity. Possible explanations were established by considering the differences and similarities between the geometries and electronic structures of reactive and unreactive cage alcohols. ROMP of cage monomers based on 1 were mostly unsuccessful. Only the cage monomer 127 showed some reactivity. Endocyclic cage monomers with a tetracycloundecane (TCU) framework showed no reactivity. The results from NMR experiments verified the experimental results. Hexacyclo[8.4.0.02,9.03,13.04,7.04,12]tetradec-5-en-11,14-dione (3) exhibited notable ROMP reactivity. Examination of the orbitals of the cage alkenes used in this study suggested that the reactivity of 1 and 3 could possibly be enhanced by removal of the carbonyl groups. Decarbonylation of 1 and 3 yielded the cage hydrocarbons 159 and 175, respectively. ROMP tests revealed that 175 is an excellent monomer, but 159 was unreactive. The results obtained for the ROMP reactions in this study was rationalised by considering aspects such as ring strain, energy profiles, steric constraints, and frontier orbital theory. The concept of ring strain is less useful when describing the reactivity of cage alkenes towards ROMP and therefore the concepts of fractional ring strain and fractional ring strain energy (RSEf) were developed. A possible link between RSEf and the ROMP reactivity of cage alkenes was also established. The following criteria were put forth to predict the reactivity or explain the lack of reactivity of cage alkenes towards ROMP reactions with Grubbs-I and Grubbs-II. The criteria for ROMP of cage monomers: 1. Sufficient fractional ring strain energy (RSEf). 2. A reasonable energy profile when compared to a reference compound such as cyclopentene. 3. Ability to form a metallacyclobutane intermediate with reasonable distances between different parts of the cage fragment. 4. Sufficient ability of the polymer fragment to take on a conformation that exposes the catalytic site. 5. Sufficient size, shape, orientation and energy of HOMO and/or NHOMO at the alkene functionality of the cage monomer and of the LUMO at the catalytic site. / Thesis (Ph.D. (Chemistry))--North-West University, Potchefstroom Campus, 2012

Three different types of cage crown ethers have been prepared and their complexation properties with Ag(I) have been studied. Atomic absorption, fluorescence quenching, and UV absorption have been used to study the interaction between the hosts (cage crown ethers) and guests (Ag+). For the cage-annulated crown ethers that contain aromatic rings, cation-π and π-π interactions may contribute significantly to the overall complexation ability of the host system. Piperazine groups may cooperate, and the piperazine nitrogen atoms provide unshared electrons, which may form a complex with Ag+. In addition, relatively soft donor atoms (e.g., Br) are well-suited for complexation with Ag+, which is a softer Lewis acid than alkali metal cations.

Part I. The syntheses of a series of stable ferrocenylsilane compounds and their corresponding polyradical cations are reported. Electron spin properties of these molecules were investigated by cyclic voltammetry, ESR, and magnetic susceptibility measurements. All the compounds presented, showed significant electronic communication (>100 mV) between the redox centers by CV. Part II. Baeyer-Villiger oxidation of (1,9-dimethyl-PCU-8,11-dione) was performed using m-chloroperoxybenzoic acid in 1:2 molar ratios. The product obtained was the corresponding dilactone 113. The structure of the reaction products was established unequivocally via single crystal X-ray diffraction methods. The reaction of the 1,9-dimethyl-PCU-8,11-dione with 1:1 molar ratio of m-chloroperoxybenzoic acid produced again the dilactone 113, and not the expected monolactone 114. Ceric ammonium nitrate (CAN) promoted oxidation reaction of 1,9-dimethyl-PCU-8,11-dione afforded a mixture of dimethylated lactones, which indicated unique reaction mechanism pathways. These individual isomers, 115 and 116, have been isolated from these mixtures via column chromatography by using silica gel as adsorbent followed by fractional recrystallization of individual chromatography fractions. Structures of these pure products have been established unequivocally by application of single crystal X-ray crystallographic methods.

In this study a number of cage alkenes were synthesised and tested for activity towards ringopening metathesis polymerisation (ROMP) with the commercially available catalysts 55 (Grubbs-I) and 56 (Grubbs-II). The first group of monomers are derivatives of tetracyclo[6.3.0.04,1105,9]undec-2-en-6-one (1). The synthesis of these cage alkenes are summarised in Scheme 7.1. The cage alkene 126b was synthesised by a Diels-Alder reaction between 1 and hexachlorocyclopentadiene (9, Scheme 7.2). The geometry of 126b was determined from XRD data. Knowledge of the geometry of 126b also established the geometry of 127 since conformational changes during the conversion from 126b to 127 are unlikely. Synthesis of the cage alkene 125 by the cycloaddition of 9 to 118 failed. The cage alkene exo-11- hydroxy-4,5,6,7,16,16-hexachlorohexacyclo[7.6.1.03,8.02,13.010,14]hexa-dec-5-ene (124, Scheme 7.3) could therefore not be prepared. Synthesis of 125 by reduction of 126b with various reduction systems was not successful. Theoretical aspects of these reactions were investigated with molecular modelling. A possible explanation for the unreactive nature of 126b towards reduction is presented, but the lack of reactivity of 118 towards 9 eluded clear explanations. The synthesis of cage alkenes from 4-isopropylidenepentacyclo[5.4.0.02,6.03,10.05,9]-undecane-8,11- dione (23) did not meet with much success (Scheme 7.4). Numerous synthetic methods were investigated to affect the transformation from 134a/134b to 135 (Scheme 7.5). These attempts evolved into theoretical investigations to uncover the reasons for the observed reactivity. Possible explanations were established by considering the differences and similarities between the geometries and electronic structures of reactive and unreactive cage alcohols. ROMP of cage monomers based on 1 were mostly unsuccessful. Only the cage monomer 127 showed some reactivity. Endocyclic cage monomers with a tetracycloundecane (TCU) framework showed no reactivity. The results from NMR experiments verified the experimental results. Hexacyclo[8.4.0.02,9.03,13.04,7.04,12]tetradec-5-en-11,14-dione (3) exhibited notable ROMP reactivity. Examination of the orbitals of the cage alkenes used in this study suggested that the reactivity of 1 and 3 could possibly be enhanced by removal of the carbonyl groups. Decarbonylation of 1 and 3 yielded the cage hydrocarbons 159 and 175, respectively. ROMP tests revealed that 175 is an excellent monomer, but 159 was unreactive. The results obtained for the ROMP reactions in this study was rationalised by considering aspects such as ring strain, energy profiles, steric constraints, and frontier orbital theory. The concept of ring strain is less useful when describing the reactivity of cage alkenes towards ROMP and therefore the concepts of fractional ring strain and fractional ring strain energy (RSEf) were developed. A possible link between RSEf and the ROMP reactivity of cage alkenes was also established. The following criteria were put forth to predict the reactivity or explain the lack of reactivity of cage alkenes towards ROMP reactions with Grubbs-I and Grubbs-II. The criteria for ROMP of cage monomers: 1. Sufficient fractional ring strain energy (RSEf). 2. A reasonable energy profile when compared to a reference compound such as cyclopentene. 3. Ability to form a metallacyclobutane intermediate with reasonable distances between different parts of the cage fragment. 4. Sufficient ability of the polymer fragment to take on a conformation that exposes the catalytic site. 5. Sufficient size, shape, orientation and energy of HOMO and/or NHOMO at the alkene functionality of the cage monomer and of the LUMO at the catalytic site. / Thesis (Ph.D. (Chemistry))--North-West University, Potchefstroom Campus, 2012

Magister Pharmaceuticae - MPharm / Recent scientific findings have highlighted the beneficial roles of polycyclic cage compounds in neurodegenerative disorders such as Alzheimer's and Parkinson's diseases. Further interest into the chemistry of these compounds is stimulated by their remarkable ability to improve the pharmacokinetics profile of known neuroprotective agents. As potent lipophilic scaffolds, they can be employed to target the brain delivery of desired compounds. Inflammation is a key mediator of neuronal cell's degeneration as activated microglia and other inflammatory mediators propagate oxidative damage and neuronal loss. Epidemiological and clinical evidence suggests that non-steroidal anti-inflammatory drugs (NSAIDs) slow down the progression and onset of neurodegenerative diseases. The beneficial effects of NSAIDs in ND can be attributed to their ability to inhibit cyclooxygenase enzymes thereby halting the biosynthesis of prostaglandins (PG) which are powerful mediators of inflammation. NSAIDs also inhibit the expression of pro- inflammatory genes. Despite their potential neuroprotective activity, NSAIDs are poorly lipophilic due to the presence of polar carboxylic acid groups and will therefore ionise at physiological pH, deterring them from reaching the desired site of action in the central nervous system (CNS).

Au cours de cette thèse, nous nous sommes intéressés à la préparation de nouveaux catalyseurs dérivés de la pyridine. En utilisant l’échelle de réactivité de Mayr, nous avons également cherché à quantifier l’effet d’un transfert de charge sur la nucléophilicité d’une pyridine. De plus, à travers un volet de trois méthodologies, nous avons étudiés leur activité en organocatalyse en tant que catalyseur sur des composés de natures très différentes (nitroalcènes, β-lactames et furan-2,3-diones). Enfin, dans un autre registre, nous avons développé la synthèse de nouvelles cages organiques chirales et fonctionnalisées parformation de liaisons imines réversibles. Nous avons également évalué leurs performances entant que cryptants. / During my PhD, we were interestedin the synthesis of new organocatalystsderivated from pyridine. Then, we tried toquantify a charge transfer effect towardpyridine nucleophilicity using a physicalorganic chemistry tool: the Mayr’s RelativityScale. Moreover, we also evaluated theircatalytic activity through three variousmethodologies involving different kind ofcompounds: nitroalkenes, β-lactams and furan-2,3-diones.To finish, we developed a straightforwardsynthesis of chiral, tunable and functionnalizedorganic cage compounds by imine reversiblebond formation. We also evaluated theirperformances as cryptands.

<p>The basic building blocks in molecular electronics often correspond to conjugated molecules. A compound class consisting of rigid rod-like staffane molecules with the heavier Group 14 elements Si, Ge, Sn and Pb at their bridgehead positions has now been investigated. Herein these oligomers are called heavy-core or Si-, Ge-, Sn- or Pb-core staffanes. These compounds benefit from interaction through their bicyclo[1.1.1]pentane monomer units. Quantum chemical calculations were performed to probe their geometries, stabilities and electronic properties associated with conjugation.</p><p>The stabilities of the bicyclo[<i>n.n.n</i>]alkane and [<i>n.n.n</i>]propellanes (1 ≤ <i>n</i> ≤ 3) with C, Si, Ge and Sn at the bridgehead positions were studied by calculation of homodesmotic ring strain energies. The bicyclic compounds with <i>n</i> = 1 and Si, Ge or Sn at bridgehead positions have lower strain than the all-carbon compound.</p><p>A gradually higher polarizability exaltation is found as the bridgehead element is changed from C to Si, Ge, Sn or Pb. The ratio between longitudinal and average polarizability also increases gradually as Group 14 is descended, consistent with enhanced conjugation in the heavier oligomers.</p><p>The localization of polarons in C-, Si- and Sn-core staffane radical cations was calculated along with internal reorganization energies. The polaron is less localized in Si- and Sn-core than in C-core staffane radical cation. The reorganization energies are also lower for the heavier staffanes, facilitating hole mobility when compared to the C-core staffanes.</p><p>The effect of the bicyclic structure on the low valence excitations in the UV-spectra of compounds with two connected disilyl segments was also investigated. MS-CASPT2 calculations of 1,4-disilyl- and 1,4-bis(trimethylsilyl)-1,4-disilabicyclo[2.2.1]heptanes and 1,4-disilyl- and 1,4-bis(trimethylsilyl)-1,4-disilabicyclo[2.1.1]hexanes revealed that although the bicyclic cage separates the two disilyl chromophores, there is a strong red-shift of the lowest valence excitations when compared to an isolated disilane.</p>